Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:SOLARA
Clear all filters
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
positive
Business Standard - Markets 3d ago

Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why

Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.

ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
Mankind Pharma partners Denovo Sciences for AI-led drug discovery
positive
ET Markets - Industry 9d ago

Mankind Pharma partners Denovo Sciences for AI-led drug discovery

Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to significantly cut down early research timelines, enhance the quality of potential drug candidates, and ensure only the most promising ones advance. By combining Mankind Pharma's R&D prowess with Denovo's AI platform, the companies expect to bring effective and accessible treatments to patients faster, marking a significant step in innovation-driven research.

ADVANCEMANKINDSOLARASPARCChemicalsHealthcare
Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery
positive
ET Markets - Industry 10d ago

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery

Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partnership aims to significantly shorten development timelines, improve the quality of potential drug candidates, and identify the most promising options. By integrating AI with human expertise, the companies are set to accelerate the delivery of effective and accessible new medicines to patients, marking a significant step forward in pharmaceutical innovation.

MANKINDSOLARAHealthcare
NEWS
positive
Business Standard - Markets 14d ago

USFDA inspects Auroactive Pharma's manufacturing unit in Andhra Pradesh

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) conducted an inspection at Auroactive Pharma (a wholly owned subsidiary of the Company), which manufactures Active Pharmaceutical Ingredients (API) & Pharmaceutical Formulation Intermediates, situated at Sy Nos 231, 285 to 291, Sancham Village, Ranasthalam Mandal, Srikakulam District, 523 409, Andhra Pradesh, from 22 June 2026, to 26 June 2026.

AUROPHARMASOLARAVIDHIINGChemicalsHealthcare
NEWS
positive
Business Standard - Markets 17d ago

Crisil Ratings upgrades ratings of Solara Active Pharma to 'BBB+/A2'

Solara Active Pharma Sciences said that Crisil Ratings has upgraded its ratings on the bank facilities of the company to 'Crisil BBB+/Stable/Crisil A2' from 'Crisil BBB/Stable/Crisil A3+'.

BANKINDIACRISILSOLARAFinancial ServicesHealthcare
API prices fall as West Asia tensions ease, boosting Indian pharma sector
positive
ET Markets - Industry 24d ago

API prices fall as West Asia tensions ease, boosting Indian pharma sector

Prices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West Asia, which has brought stability to supply chains. Indian pharmaceutical manufacturers are breathing a sigh of relief as they manage to offset rising input expenses.

SOLARAHealthcare
True North buys 25% stake in pharma co Embio
positive
ET Markets - Industry 44d ago

True North buys 25% stake in pharma co Embio

Private equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients for regulated markets. This investment will support Embio's research and development and capacity expansion. It will also help scale their contract development and manufacturing business. Embio specializes in complex APIs and synthetic biology.

BFINVESTSOLARASPARCFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 57d ago

Solara Active Pharma spurts after reporting turnaround Q4 perfromance

Solara Active Pharma Sciences soared 15.20% to Rs 584.85 after the company reported consolidated net profit to Rs 9.60 crore in Q4 FY26 compared with net loss of Rs 2.10 crore in Q4 FY25.

SOLARAHealthcare
NEWS
positive
Business Standard - Markets 57d ago

Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter

Sales rise 41.86% to Rs 387.29 crore

SOLARAHealthcare
Solara Active Q4 Results: Stock jumps 15% after profitability returns, revenue growth
positive
CNBC TV18 - Markets 57d ago

Solara Active Q4 Results: Stock jumps 15% after profitability returns, revenue growth

Solara Active Pharma Sciences returned to profitability in the fourth quarter as revenue surged 42%, although persistent weakness in the Ibuprofen business continued to weigh on margins and overall profitability.

PERSISTENTSOLARAHealthcareInformation Technology
Q4 Results LIVE Updates: JSW Steel, Muthoot react to results; Tata Steel, Power Grid report today
positive
CNBC TV18 - Markets 57d ago

Q4 Results LIVE Updates: JSW Steel, Muthoot react to results; Tata Steel, Power Grid report today

Q4 Results LIVE Updates: Two Nifty 50 companies Tata Steel and Power Grid along with broader market names like ITC Hotels, Hindustan Copper, Godfrey Phillips, Gland Pharma, Cochin Shipyard, Deepak Nitrite, Balrampur Chini, Arvind, Bajaj Electricals, Aarti Drugs, Aether Industries, Alembic Pharma, NCC, NHPC, Premier Energies, SAIL, SJVN, Solara Active Pharma, Symphony, Thangamayil, Triveni Engineering, VST Tillers, are among the companies reporting their earnings today. JSW Steel, Muthoot Finance, Apollo Tyres, Endurance Tech, Voltas, are some of the other result reactions today. Watch this space for all the LIVE updates.

AARTIDRUGSAARTIINDABHAPOWERAETHERALEMBICLTDALLETECAONETMMQ50AONETOTALAPOLLOAPOLLOTYREAPOLSINHOTARVINDBAJAJELECBAJAJHFLBAJAJSTBAJFINANCEBALRAMCHINBANKBETFCOCHINSHIPDEEPAKNTRENDURANCEGLANDGODFRYPHLPGVPILHGINFRAHINDCOPPERITCITCHOTELSJSWHLJSWINFRAJSWSTEELLIQUIDBETFLTFMBELMOCAPITALMSPLMUTHOOTFINNCCNETFNHPCNIFTYBETFNPBETPARTHPFCPHARMABEESPOWERGRIDPREMIERPREMIERENESAILSALSTEELSJVNSOLARASYMPHONYTATAPOWERTATASTEELTATATECHTECHTNIDETFTRIVENIVIVIANAVOLTASVSTINDZTECHAutomobile and Auto ComponentsCapital Goods
Sun Pharma’s Ilumya expansion bid gets USFDA nod for review
positive
ET Markets - Industry 116d ago

Sun Pharma’s Ilumya expansion bid gets USFDA nod for review

Sun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for treating adults with active psoriatic arthritis. This marks a crucial step for Sun Pharma in expanding its medicine portfolio. The US regulator has accepted the application for review.

SOLARASPARCSUNPHARMAHealthcare
2
Next